Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,100 | -22,680 | -138,375 | -28,393 | -13,291 |
| Depreciation Amortization | 29,784 | 14,493 | 51,710 | 37,987 | 24,153 |
| Income taxes - deferred | N/A | N/A | 754,942 | -9,808 | -4,276 |
| Accounts receivable | 19,771 | 17,883 | 84,395 | 93,180 | 89,968 |
| Accounts payable and accrued liabilities | 889 | -3,682 | 5,284 | 3,625 | 1,639 |
| Other Working Capital | -4,471 | -10,641 | 97,844 | 95,465 | 86,893 |
| Other Operating Activity | 4,094 | -3,840 | -729,576 | -73,622 | -80,818 |
| Operating Cash Flow | $8,967 | $-8,467 | $126,224 | $118,434 | $104,268 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,218 | -5,665 | -65,553 | -48,754 | -32,927 |
| Net Acquisitions | N/A | N/A | -69,622 | -69,622 | -69,622 |
| Other Investing Activity | 4,792 | 1,421 | 12,865 | 8,969 | 8,662 |
| Investing Cash Flow | $-10,426 | $-4,244 | $-122,310 | $-109,407 | $-93,887 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,013 | -1,505 | -5,772 | -4,270 | -2,786 |
| Common Stock Issued | N/A | N/A | N/A | 331 | N/A |
| Other Financing Activity | 2,681 | 945 | -55,318 | -57,621 | -59,557 |
| Financing Cash Flow | $-332 | $-560 | $-61,090 | $-61,560 | $-62,343 |
| Beginning Cash Position | 574,962 | 574,962 | 632,138 | 632,138 | 632,138 |
| End Cash Position | 573,171 | 561,691 | 574,962 | 579,605 | 580,176 |
| Net Cash Flow | $-1,791 | $-13,271 | $-57,176 | $-52,533 | $-51,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,967 | -8,467 | 126,224 | 118,434 | 104,268 |
| Capital Expenditure | -15,218 | -5,665 | -65,553 | -48,754 | -32,927 |
| Free Cash Flow | -6,251 | -14,132 | 60,671 | 69,680 | 71,341 |